News Sentiment

BVS sentiment intelligence

Bioventus Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 68 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 11.88 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

76/100 classification confidence.

Company focus 56

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+13.4% over one week, +39.6% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Hillsdale Investment Management Inc. Raises Stake in Bioventus Inc. $BVS

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 76/100 classification
One-week reaction 13.4% Price confirming higher
Trend fit Trend active 39.6% over four weeks
Fair value 60.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 53
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 56
Industry context 12
Sector context 0

Sources

Coverage mix

Publishers
TradingView 29
Market source 19
MarketBeat 2
simplywall.st 2
Stock Titan 2
StockStory 2
Zacks 1
Bölüm Sonu Canavarı 1

Event Lens

What the news is about

Classified themes
Earnings 33
Market update 24
Balance sheet 6
Analyst action 3
Deals and strategy 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 68
TradingView Direct company coverage

Bioventus, Inc. Class A Revenue Breakdown – LS:A2APNA

This article provides a revenue breakdown for Bioventus, Inc. Class A, trading under the symbol A2APNA on Lang & Schwarz Tradecenter. It highlights that the company generated 483.68 million EUR last year, with Pain Treatments being its highest-performing segment. The United State

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 00:40
Source
TradingView
TradingView Direct company coverage

Cost of goods sold of Bioventus, Inc. Class A – LS:A2APNA

The article focuses on the cost of goods sold for Bioventus, Inc. Class A (LS:A2APNA), providing financial data on this specific metric. It indicates that the information is "Made by humans" and sources market data from ICE Data Services and reference data from FactSet.

Tone
Neutral 50/100
Event
Market update
Published
05 Jul 2026 23:40
Source
TradingView
TradingView Direct company coverage

Pretax income of Bioventus, Inc. Class A – LS:A2APNA

The article focuses on the pretax income of Bioventus, Inc. Class A, identified by its stock symbol LS:A2APNA on the Lang & Schwarz Tradecenter. It indicates that the market is currently closed and no trades have occurred for this stock. The content appears to be a financial data

Tone
Neutral 50/100
Event
Market update
Published
05 Jul 2026 22:39
Source
TradingView
TradingView Direct company coverage

Bioventus, Inc. Class A Revenue Breakdown – DUS:4B8

Bioventus, Inc. Class A (DUS:4B8) generated 483.68 million EUR in revenue last year. The Pain Treatments segment was the top-performing segment, contributing 237.60 million EUR. The United States was the largest regional contributor, accounting for 427.49 million EUR.

Tone
Neutral 50/100
Event
Earnings
Published
30 Jun 2026 17:40
Source
TradingView
TradingView Direct company coverage

Average basic shares outstanding of Bioventus, Inc. Class A – DUS:4B8

This article provides financial data for Bioventus, Inc. Class A (DUS:4B8) on the Dusseldorf Stock Exchange. Specifically, it focuses on the "Average basic shares outstanding" for the company. The content appears to be a stub or a data point from a larger financial platform like

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 16:40
Source
TradingView
TradingView Direct company coverage

Bioventus, Inc. Class A Actuals & Estimates (NASDAQ:BVS)

This article provides an overview of Bioventus Inc. (NASDAQ: BVS) stock, including its current price, historical performance, analyst forecasts, and financial data. It details the company's market capitalization, volatility, recent earnings, revenue figures, and upcoming earnings

Tone
Positive 71/100
Event
Earnings
Published
26 Jun 2026 07:40
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Bioventus, Inc. Class A – FWB:4B8

The article provides information on the "Price to earnings forward" metric for Bioventus, Inc. Class A (FWB:4B8) on the Frankfurt Stock Exchange. It indicates no current trading activity with the market closed, and the specific value of the metric is listed as "Period Value Chang

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 07:11
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Bioventus, Inc. Class A – TRADEGATE:4B8

This article displays the "Price to earnings forward" value for Bioventus, Inc. Class A (4B8) on the Tradegate Exchange. It indicates that the market is closed with no current trades. The data is provided by ICE Data Services and FactSet.

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 06:11
Source
TradingView